Neurocrine Biosciences, Inc.
NBIX
$118.78
$1.911.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 943.50M | 1.08B | 1.23B | 1.04B | 1.21B |
| Total Receivables | 516.00M | 479.10M | 481.10M | 468.20M | 450.70M |
| Inventory | 59.10M | 57.40M | 45.80M | 42.50M | 37.20M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 119.30M | 112.10M | 121.70M | 120.20M | 100.50M |
| Total Current Assets | 1.64B | 1.72B | 1.88B | 1.67B | 1.80B |
|
|
|||||
| Total Current Assets | 1.64B | 1.72B | 1.88B | 1.67B | 1.80B |
| Net Property, Plant & Equipment | 589.20M | 592.00M | 337.30M | 343.00M | 346.10M |
| Long-term Investments | -- | 5.70M | 6.10M | -- | -- |
| Goodwill | -- | 5.70M | 6.10M | -- | -- |
| Total Other Intangibles | 36.40M | 36.50M | 34.50M | 33.50M | 34.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 514.70M | 495.50M | 509.90M | 477.30M | 429.10M |
| Total Assets | 3.69B | 3.72B | 3.54B | 3.31B | 3.47B |
|
|
|||||
| Total Accounts Payable | 110.00M | 110.00M | 95.70M | 107.20M | 87.30M |
| Total Accrued Expenses | 339.80M | 351.60M | 297.00M | 251.30M | 305.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.60M | 40.60M | 34.80M | 35.40M | 157.80M |
| Total Finance Division Other Current Liabilities | 27.50M | 5.50M | 2.20M | 4.60M | 162.70M |
| Total Other Current Liabilities | 27.50M | 5.50M | 2.20M | 4.60M | 162.70M |
| Total Current Liabilities | 522.90M | 507.70M | 429.70M | 398.50M | 712.90M |
|
|
|||||
| Total Current Liabilities | 522.90M | 507.70M | 429.70M | 398.50M | 712.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 447.50M | 455.10M | 251.40M | 256.20M | 252.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 181.60M | 166.20M | 135.00M | 141.10M | 120.50M |
| Total Liabilities | 1.15B | 1.13B | 816.10M | 795.80M | 1.09B |
|
|
|||||
| Common Stock & APIC | 2.53B | 2.55B | 2.62B | 2.56B | 2.50B |
| Retained Earnings | -5.30M | 29.20M | 81.10M | -48.70M | -113.70M |
| Treasury Stock & Other | 9.00M | 5.80M | 14.50M | 2.50M | 3.30M |
| Total Common Equity | 2.54B | 2.59B | 2.72B | 2.51B | 2.39B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.54B | 2.59B | 2.72B | 2.51B | 2.39B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.54B | 2.59B | 2.72B | 2.51B | 2.39B |
|
|
|||||